Surgical treatment of secondary refractory glaucoma in chronic uveitis with corneal dystrophy (clinical case)
Anna V. Starostina , Aila A. Uyanaeva , Amina A. Adzhieva , Mariam R. Taevere , Margarita R. Khabazova
Journal of Clinical Practice ›› 2024, Vol. 15 ›› Issue (2) : 73 -80.
Surgical treatment of secondary refractory glaucoma in chronic uveitis with corneal dystrophy (clinical case)
BACKGROUND: Uveitis is the inflammation of the iris, ciliary body, vitreous, retina, or vascular membrane, in which the most common complication is a secondary increase in intraocular pressure that is difficult to compensate with antihypertensive drugs. Ahmed valve implantation in uveal glaucoma is an effective surgical method to reduce intraocular pressure.
CLINICAL CASE DESCRIPTION: In the Department of Surgical Treatment of Glaucoma of the S. Fyodorov Eye Microsurgery Federal State Institution, Ahmed valve implantation was performed in two patients with refractory, repeatedly operated uveal glaucoma. As a result of valve implantation, in both cases, compensation of intraocular pressure within up to 15 months after surgery was possible.
CONCLUSION: Ahmed valve implantation in secondary uveal repeatedly operated glaucoma in patients with chronic uveitis and corneal dystrophy achieved compensation of intraocular pressure and preserved visual functions.
secondary glaucoma / uveal glaucoma / intraocular pressure / Ahmed valve drainage
| [1] |
Kalogeropoulos D, Sung VC. Pathogenesis of uveitic glaucoma. J Curr Glaucoma Pract. 2018;12(3):125–138. doi: 10.5005/jp-journals-10028-1257 |
| [2] |
Škrlová E, Svozílková P, Heissigerová J, Fichtl M. Pathogenesis and current methods of treatment of secondary uveitic glaucoma. A review. Cesk Slov Oftalmol. 2023;79(3):111–115. EDN: IXZVML doi: 10.31348/2023/7 |
| [3] |
Sng CC, Ang M, Barton K. Uveitis and glaucoma: New insights in the pathogenesis and treatment. Prog Brain Res. 2015;(221):243–269. doi: 10.1016/bs.pbr.2015.06.008 |
| [4] |
Mercieca K, Steeples L, Anand N. Deep sclerectomy for uveitic glaucoma: Long-term outcomes. Eye (Lond). 2017;31(7): 1008–1019. doi: 10.1038/eye.2017.80 |
| [5] |
Valenzuela F, Oportus MJ, Pérez CI, et al. Ahmed glaucoma drainage implant surgery in the management of refractory uveitic glaucoma: Long-term follow up. Arch Soc Esp Oftalmol (Engl Ed). 2018;93(9):431–438. doi: 10.1016/j.oftal.2018.05.011 |
| [6] |
Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma. 200211(3):189–196. doi: 10.1097/00061198-200206000-00005 |
| [7] |
Ramdas WD, Pals J, Rothova A, Wolfs RC. Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):143–151. EDN: CTNDSW doi: 10.1007/s00417-018-4156-9 |
| [8] |
Ceballos EM, Parrish RK, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology. 2002;109(12):2256–2260. doi: 10.1016/s0161-6420(02)01294-0 |
| [9] |
Luzu J, Baudouin C, Hamard P. The role of Ahmed glaucoma valve in the management of refractory glaucoma: Long-term outcomes and complications. Eur J Ophthalmol. 2021;31(5):2383–2389. doi: 10.1177/1120672120968733 |
| [10] |
Da Mata A, Burk SE, Netland PA, et al. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology. 1999;106(11):2168–2172. doi: 10.1016/S0161-6420(99)90500-6 |
| [11] |
Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995; 120(1):23–31. doi: 10.1016/s0002-9394(14)73755-9 |
Eco-Vector
/
| 〈 |
|
〉 |